Currently Viewing:
COA 2017-ONCOLOGY PAYMENT REFORM
How Has the OCM Evolved? Year 1 Provider Updates
October 24, 2017
Will 2-Sided Risk Be a Reality in OCM?
October 24, 2017
Dr Lucio Gordan: How Practices and Payers Work Together to Implement OCM
October 24, 2017
Dr Jeff Patton Highlights Challenges Encountered With Implementing OCM
October 24, 2017
Physicians Need Clearer Metrics Before Taking on 2-Sided Risk
October 25, 2017
Terrill Jordan: Education and Data Are Key for OCM Success
October 25, 2017
The Commercial Payer OCM Experience: Year 1
October 25, 2017
Stakeholders Weigh-in on Payment Reform in Cancer Care
October 25, 2017
Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug Pricing
November 05, 2017
Dr Ira Klein on Pharmaceutical Interest in Alternative Payment Models
December 07, 2017
Dr Lucio Gordan: Improving Population Health Through Alternative Payment Models
December 08, 2017
Terrill Jordan: Year 1 Feedback on OCM
December 22, 2017
Sarah Cevallos: Physicians Need More Data to Determine if 2-Sided Risk is Appropriate
December 26, 2017
Terrill Jordan Discusses Making Refinements in Year 2 of OCM
January 03, 2018
Judy Berger on What Southwest Airlines Is Doing in Oncology
January 04, 2018
Bo Gamble on COA's Role in 2018
January 05, 2018
Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer Care
January 07, 2018
Dr Roger Brito: What Patients Should Know About Alternative Payment Models, OCM
January 09, 2018
Sarah Cevallos on Her Advice for Practices Looking to Participate in OCM
January 10, 2018
Dr Peter Aran on Involving Providers in Development Process of New Reimbursement Models
January 11, 2018
Dr Jeff Patton Discusses Preparing for OCM, Seeing Improved Outcomes and Savings
January 12, 2018
David Merrill and John Robinson Discuss Barriers to APMs, Factors of Interest
January 15, 2018
Dr Mark Fendrick: Setting Cost-Sharing Based on Value, Not Price, in Cancer Care
January 18, 2018
Currently Reading
Terrill Jordan Discusses the Process of Customizing an EMR to Adapt to OCM
January 19, 2018

Terrill Jordan Discusses the Process of Customizing an EMR to Adapt to OCM

In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.


In order to adapt to the Oncology Care Model (OCM), Regional Cancer Care Associates had to undergo the process of adjusting and customizing its electronic medical records, explained CEO Terrill Jordan.

Transcript

Did you have to upgrade your electronic health records to adapt to OCM requirements, and what was that process like?

We did and it wasn’t so much as upgrade as we had to customize a lot of the workflows. What we found was that the EMRs weren’t developed with value based in mind while there were a lot of structure fields, the structure fields weren’t in a place to be used within the workflow. So what we had to do was customize little drop down boxes, we had to customize different fields so our clinicians could put structured data in along with their daily exercise of seeing patients. That was the main change with the EMR.

In terms of some of the other software we had, we found that a lot of the other software wasn’t meant to interface with the EMR—and the EMR being so critical to our understanding of the clinical, marrying that up with the claims data, marrying that up with our payment data—we found that the interface was also an issue.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up